DR. JOSEF NEU, MD
Medical Practice at Archer Rd, Gainesville, FL
License number
Florida ME44186
Category
Medical Practice
Type
Pediatrics
License number
Florida ME44186
Category
Medical Practice
Type
Neonatal-Perinatal Medicine
Address
Address
1600 SW Archer Rd, Gainesville, FL 32610
Phone
(352) 392-4193
(352) 846-3937 (Fax)
(352) 846-3937 (Fax)
Personal information
See more information about JOSEF NEU at radaris.comName
Address
Phone
6516 93Rd Ave, Gainesville, FL 32608
6516 93Rd St, Gainesville, FL 32608
6516 SW 93Rd Ave, Gainesville, FL 32608
Organization information
See more information about JOSEF NEU at bizstanding.comJosef Neu MD
1600 SW Archer Rd #2, Gainesville, FL 32610
Industry:
Pediatrician
Phone:
(352) 273-8985 (Phone), (352) 392-4193 (Phone)
Description:
There are 11 doctors at this site. Surgery is not performed at this site.
Josef Neu
Categories:
Physicians & Surgeons
Professional information
Josef Neu, Gainesville FL
Specialties:
Pediatrician
Address:
1600 Sw Archer Rd, Gainesville, FL 32610
Education:
University of Wisconsin, School of Medicine and Public Health - Doctor of Medicine
Stanford Hospital & Clinics - Fellowship - Perinatology
Johns Hopkins Hospital - Residency - Pediatrics
Stanford Hospital & Clinics - Fellowship - Perinatology
Johns Hopkins Hospital - Residency - Pediatrics
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Neonatal-Perinatal Medicine (Pediatrics)
Josef Neu, Gainesville FL
Specialties:
Pediatrics, Neonatal-Perinatal Medicine, Maternal & Fetal Medicine
Work:
Shands at AGH
1600 Sw Archer Rd, Gainesville, FL 32610
1600 Sw Archer Rd, Gainesville, FL 32610
Education:
University of Wisconsin at Madison (1975) Pediatrics
Method For Treating Or Preventing Systemic Inflammation In Formula-Fed Infants
US Patent:
2006023, Oct 19, 2006
Filed:
Apr 15, 2005
Appl. No.:
11/106793
Inventors:
Robert McMahon - Evansville IN, US
Josef Neu - Gainesville FL, US
Josef Neu - Gainesville FL, US
International Classification:
A01N 65/00, A01N 63/00
US Classification:
424093100
Abstract:
The present invention is directed to a novel method for treating or preventing systemic inflammation in a formula-fed infant. The method comprises administering a therapeutically effective amount of LGG to the infant.
Enternal Administration Of Arginine And Glutamine For Abnormal Vascular Proliferation
US Patent:
2006022, Oct 12, 2006
Filed:
Mar 29, 2006
Appl. No.:
11/392913
Inventors:
Joshua Anthony - Evansville IN, US
Josef Neu - Gainesville FL, US
Maria Grant - Fairfield FL, US
Josef Neu - Gainesville FL, US
Maria Grant - Fairfield FL, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
University of Florida Research Foundation, Incorporated - Gainesville FL
University of Florida Research Foundation, Incorporated - Gainesville FL
International Classification:
A61K 38/04, A61K 31/198
US Classification:
514019000, 514563000, 514565000
Abstract:
The subject invention provides a method and compositions for preventing and/or treating abnormal vascular proliferation in a human infant where the method involves enterally administering arginine and glutamine to the infant in about equimolar amounts to provide a total amount of arginine and glutamine that is effective to prevent or treat the abnormal vascular proliferation. Arginyl-glutamine dipeptide was shown to be an advantageous form in which to provide the two amino acids.
Arginyl-Glutamine Dipeptide For Treatment Of Pathological Vascular Proliferation
US Patent:
2005008, Apr 28, 2005
Filed:
Sep 27, 2004
Appl. No.:
10/950734
Inventors:
Josef Neu - Gainesville FL, US
Maria Grant - Fairfield FL, US
Joshua Anthony - Evansville IN, US
Maria Grant - Fairfield FL, US
Joshua Anthony - Evansville IN, US
International Classification:
A61K038/04, A61K047/00
US Classification:
424439000, 514019000
Abstract:
The subject invention provides dipeptides useful in preventing pathological proliferation of blood vessels. The dipeptides of the subject invention are particularly advantageous because they are stable, bioavailable, and can be formulated in an aqueous solution, and in particular, into infant formulations.
Arginyl-Glutamine Dipeptide For Treatment Of Pathological Vascular Proliferation
US Patent:
2005007, Mar 31, 2005
Filed:
Sep 27, 2004
Appl. No.:
10/951150
Inventors:
Josef Neu - Gainesville FL, US
Maria Grant - Fairfield FL, US
Maria Grant - Fairfield FL, US
International Classification:
A61K038/04
US Classification:
514019000
Abstract:
The subject invention provides dipeptides useful in preventing pathological proliferation of blood vessels. The dipeptides of the subject invention are particularly advantageous because they are stable, bioavailable, and can be formulated in an aqueous solution.
Materials And Methods For Treatment Of Pathological Ocular Vascular Proliferation
US Patent:
2009019, Jul 30, 2009
Filed:
Dec 17, 2008
Appl. No.:
12/336814
Inventors:
Josef Neu - Gainesville FL, US
Maria B. Grant - Fairfield FL, US
Joshua Anthony - Evansville IN, US
Kristin Morris - Evansville IN, US
Eduard Poels - Newburgh IN, US
Deborah Schade - Evansville IN, US
Hugh Tucker - Evansville IN, US
Maria B. Grant - Fairfield FL, US
Joshua Anthony - Evansville IN, US
Kristin Morris - Evansville IN, US
Eduard Poels - Newburgh IN, US
Deborah Schade - Evansville IN, US
Hugh Tucker - Evansville IN, US
International Classification:
A61K 31/202, A61P 35/00
US Classification:
514560
Abstract:
The subject invention provides for the administration of docosahexaenoic acid in preventing pathological proliferation of blood vessels. The compositions of the subject invention are particularly advantageous because they are stable, bioavailable, and can be formulated in an aqueous solution.
Dipeptides For Prevention Of Muscle Breakdown And Microbial Infection
US Patent:
8133868, Mar 13, 2012
Filed:
Oct 17, 2008
Appl. No.:
12/253590
Inventors:
Josef Neu - Gainesville FL, US
Assignee:
University of Florida Research Foundation, Inc. - Gainesville FL
International Classification:
A61K 38/05, A01N 45/00
US Classification:
514 2191, 530300, 514168
Abstract:
The subject invention provides dipeptides useful in promoting healthy muscle tissues as well as effective immune responses. The dipeptides of the subject invention are particularly advantageous because they are stable, bioavailable, and can be formulated in an aqueous solution.
Method For The Utilization Of And Product Containing Inactivated Probiotic
US Patent:
2008020, Aug 28, 2008
Filed:
Feb 22, 2008
Appl. No.:
12/035705
Inventors:
Robert J. McMahon - Evansville IN, US
William Michael Russell - Evansville IN, US
Udo Herz - Evansville IN, US
Josef Neu - Gainesville FL, US
William Michael Russell - Evansville IN, US
Udo Herz - Evansville IN, US
Josef Neu - Gainesville FL, US
International Classification:
A61K 35/74, A61P 29/00
US Classification:
424 9345, 424 934
Abstract:
A novel method and product utilizing or containing one or more inactivated probiotics.
Method For Reducing Or Preventing Systemic Inflammation
US Patent:
2008020, Aug 28, 2008
Filed:
Feb 22, 2008
Appl. No.:
12/035718
Inventors:
Udo Herz - Evansville IN, US
Robert J. McMahon - Evansville IN, US
William Michael Russell - Evansville IN, US
Josef Neu - Gainesville FL, US
Robert J. McMahon - Evansville IN, US
William Michael Russell - Evansville IN, US
Josef Neu - Gainesville FL, US
International Classification:
A61K 35/74, A61P 29/00
US Classification:
424 9345
Abstract:
The present invention is directed to a novel method for treating or preventing systemic inflammation in a subject. The method administering to the subject a therapeutically effective amount of inactivated LGG.